Search research articles
Contact Us
Filters
Showing results (111-120 of 212) with videos related to
Page
of 22
Sort By:
Plos Medicine
|
July 14, 2011
Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities
Nyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 18, 2020
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
Haoli Jin, James C Reed, Sean T H Liu, et al.
Open Forum Infectious Diseases
|
March 12, 2020
Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4<sup>+</sup> T-Cell Counts in People With HIV
Joseph M Rocco, Zachary York, Chengli Shen, et al.
Antiviral Therapy
|
February 17, 2007
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148
Michael P Dubé, Julia W Wu, Judith A Aberg, et al.
AIDS Research and Human Retroviruses
|
October 13, 2005
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087
Judith A Aberg, Robert A Zackin, Susan W Brobst, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2007
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186
John G Gerber, Douglas W Kitch, Carl J Fichtenbaum, et al.
BMC Infectious Diseases
|
January 14, 2025
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19
Catharine I Paules, Jacqueline A Nordwall, Kathryn Shaw-Saliba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2004
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy
Mitchell Goldman, Robert Zackin, Carl J Fichtenbaum, et al.
Open Forum Infectious Diseases
|
May 9, 2017
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy
Meagan P O'Brien, Peter W Hunt, Douglas W Kitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2014
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women
Erna Milunka Kojic, Minhee Kang, Michelle S Cespedes, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 212) with videos related to
Sort By:
Page
of 22
Plos Medicine
|
July 14, 2011
Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities
Nyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 18, 2020
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
Haoli Jin, James C Reed, Sean T H Liu, et al.
Open Forum Infectious Diseases
|
March 12, 2020
Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4<sup>+</sup> T-Cell Counts in People With HIV
Joseph M Rocco, Zachary York, Chengli Shen, et al.
Antiviral Therapy
|
February 17, 2007
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148
Michael P Dubé, Julia W Wu, Judith A Aberg, et al.
AIDS Research and Human Retroviruses
|
October 13, 2005
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087
Judith A Aberg, Robert A Zackin, Susan W Brobst, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2007
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186
John G Gerber, Douglas W Kitch, Carl J Fichtenbaum, et al.
BMC Infectious Diseases
|
January 14, 2025
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19
Catharine I Paules, Jacqueline A Nordwall, Kathryn Shaw-Saliba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2004
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy
Mitchell Goldman, Robert Zackin, Carl J Fichtenbaum, et al.
Open Forum Infectious Diseases
|
May 9, 2017
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy
Meagan P O'Brien, Peter W Hunt, Douglas W Kitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2014
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women
Erna Milunka Kojic, Minhee Kang, Michelle S Cespedes, et al.
Page
of 22